Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Extraocular sebaceous carcinoma of the lateral neck: Molecular exclusion of Muir-Torre syndrome and management of sporadic Stage III Disease

Breadcrumb

  • Home
  • Extraocular sebaceous carcinoma of the lateral neck: Molecular exclusion of Muir-Torre syndrome and management of sporadic Stage III Disease

Alireza Izadian Bidgoli 1, Jennifer Flores 1, Elise Collins 1, Jennifer Ejeh 2, Mareena Ayad 3, Jessica Jahoda 4, 5 and Mohamed Aziz 5, * 

1 American University of the Caribbean, AUC, St. Maarten.
2 Ross University School of Medicine, Barbados.
3 Medical University of the Americas, Nevis, St. Kitts and Nevis.
4 Memorial Healthcare System, Pembroke Pines, FL, USA.
5 Research Writing & Publication (RWP), LLC, NY, USA.

Case Report

World Journal of Biology Pharmacy and Health Sciences, 2026, 26(03), 048-054

Article DOI: 10.30574/wjbphs.2026.26.3.0337

DOI url: https://doi.org/10.30574/wjbphs.2026.26.3.0337

Received on 25 April 2026; revised on 02 June 2026; accepted on 04 June 2026

Extraocular sebaceous carcinoma (SC) is a rare and aggressive adnexal malignancy that may mimic other cutaneous cancers and can be associated with Muir-Torre syndrome, creating diagnostic and management challenges. A 72-year-old man presented with an 18-month history of a slowly-growing, intermittently ulcerated, non-tender left lateral neck nodule associated with occasional bleeding. Imaging demonstrated a vascularized neck lesion with suspicious left cervical lymphadenopathy, while dermoscopy suggested an adnexal tumor. 
Punch biopsy showed an infiltrative dermal neoplasm with sebaceous differentiation, pagetoid spread, and perineural invasion. Immunohistochemistry (IHC) demonstrated diffuse positivity for androgen receptor, EMA, p63, and adipophilin, confirming the diagnosis of sebaceous carcinoma, whereas S100 and HMB-45 were negative. The tumor was staged as pT2N1M0 (stage III). Molecular testing showed microsatellite stability, excluding Lynch/Muir-Torre syndrome and supporting a sporadic etiology related to chronic ultraviolet (UV) exposure.
The patient underwent Mohs micrographic surgery with sentinel lymph node biopsy and selective neck dissection, followed by adjuvant external beam radiotherapy because of nodal involvement and perineural invasion. At 18 months of follow-up, he remained disease-free, with no evidence of local recurrence or distant metastasis. This case highlights the importance of histopathologic, IHC, and molecular evaluation in distinguishing sporadic extraocular sebaceous carcinoma from hereditary syndromic disease and guiding multidisciplinary management. 

Extraocular sebaceous carcinoma; Muir-Torre syndrome; Germline mutations in mismatch repair; Microsatellite instability; Mohs micrographic surgery; External beam radiation therapy; Ultraviolet

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0337.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Alireza Izadian Bidgoli, Jennifer Flores, Elise Collins, Jennifer Ejeh, Mareena Ayad, Jessica Jahoda and Mohamed Aziz. Extraocular sebaceous carcinoma of the lateral neck: Molecular exclusion of Muir-Torre syndrome and management of sporadic Stage III Disease. World Journal of Biology Pharmacy and Health Sciences, 2026, 26(03), 048-054. Article DOI: https://doi.org/10.30574/wjbphs.2026.26.3.0337

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution